These compounds may interact with:
Nuclear receptor coactivator 2
Potentially involved in: lung cancer; kidney cancer; carcinoma; cancer; androgen insensitivity syndrome; hiatus hernia; prostatic neoplasms; mammary neoplasms; aldosterone-producing adenoma; atypical teratoid / rhabdoid tumor; crohn's disease; gaucher disease type 1; glioblastoma; interstitial cystitis; intraductal papillary-mucinous neoplasm (ipmn); medulloblastoma; medulloblastoma, large-cell; multiple myeloma; osteosarcoma; psoriasis
Disease data sourced from Pharos.